uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020)

uniQure (QURE) posted quarterly Non-Current Deffered Revenue of $22.4 million for Q3 2020, down 6.15% year-over-year from $23.9 million in Q4 2019, and down 2.76% quarter-over-quarter from $23.0 million in Q2 2020.

Analysis

uniQure (QURE) Non-Current Deffered Revenue (2015 - 2020) Analysis & Trends

uniQure's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $22.4 million for Q3 2020.

  • In Q3 2020, Non-Current Deffered Revenue fell 6.15% year-over-year to $22.4 million; the TTM figure through Sep 2020 stood at $22.4 million (down 6.15% YoY), while the FY2019 annual figure was $23.1 million, down 19.83% from the prior year.
  • Non-Current Deffered Revenue for Q3 2020 stood at $22.4 million, down from $23.0 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $78.7 million in Q2 2017, with the low at $22.4 million in Q3 2020.
  • The 5-year median for Non-Current Deffered Revenue is $29.4 million (2018), against an average of $41.4 million.
  • The sharpest annual moves came in 2018 and 2020: Non-Current Deffered Revenue tumbled 58.27% in 2018, then slipped 6.15% in 2020.
  • uniQure's Non-Current Deffered Revenue stood at $75.6 million in 2016, then slipped by 10.85% to $67.4 million in 2017, then tumbled by 57.18% to $28.9 million in 2018, then decreased by 19.83% to $23.1 million in 2019, then decreased by 3.13% to $22.4 million in 2020.
  • Business Quant data shows QURE's Non-Current Deffered Revenue at $22.4 million in Q3 2020, $23.0 million in Q2 2020, and $23.7 million in Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 220.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 147.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 22.41 Mn
Jun 30, 2020 23.05 Mn
Mar 31, 2020 23.71 Mn
Dec 31, 2019 23.14 Mn
Sep 30, 2019 23.88 Mn
Jun 30, 2019 26.35 Mn
Mar 31, 2019 27.47 Mn
Dec 31, 2018 28.86 Mn
Sep 30, 2018 29.85 Mn
Jun 30, 2018 32.85 Mn
Mar 31, 2018 36.15 Mn
Dec 31, 2017 67.41 Mn
Sep 30, 2017 67.86 Mn
Jun 30, 2017 78.73 Mn
Mar 31, 2017 75.40 Mn
Dec 31, 2016 75.61 Mn
Dec 31, 2015 83.45 Mn